Bayer HealthCare Announces Award Winners

Today, Bayer HealthCare announced that they had awarded more than 2 million in funding to 14 recipients residing in five countries. The annual Bayer Hemophilia Awards Program (BHAP) is the largest hemophilia program, giving out more than 28 million dollars in funding to researchers and caregivers from 30 countries, awarding over 230 grants since its inception in 2002.

“BHAP, now in its twelfth year, continues to attract high-quality applicants who are committed to answering important scientific and medical questions. Through our support of their research, this year’s winners will contribute to a better understanding of hemophilia and bleeding disorders and ways to improve treatment and optimize patient outcomes,” said Prasad Mathew, MD, Vice President, Global Medical Affairs Hematology at Bayer HealthCare, via a press release from PR Newswire.

This year’s projects included cutting-edge approaches for product replacement therapy and genomic editing to correct specific gene mutations among the many other projects. The winners of BHAP this year in the United States included:

-Brian Brown, Icahn School of Medicine at Mount Sinai, New York
-Lacramioara Ivanciu, The Children’s Hospital of Philadelphia
-Juan Melero-Martin, Boston Children’s Hospital, Harvard Medical School
-Jordan Shavit, University of Michigan, Ann Arbor
-Suman Sood, University of Michigan, Ann Arbor

The recipients of these awards are selected by a global panel of clinicians, researchers and caregivers in the hemophilia field.

This year’s recipients were announced at the World Federation of Hemophilia (WFH) 2014 World Congress in Melbourne, Australia earlier this week.

Click here to learn more about BHAP and other 2014 award winners.

Photo Credit – Bayer HealthCare

webleed.org – your source for bleeding news!